InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ACTUATE THERAPEUTICS, INC.

ACTU Clue Score25
United States Fiscal year ends December CIK 0001652935
$0.64 +5.49% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.64 −92.04% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Aug 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2023Operating income−25.0Net income−24.7EPS, diluted−17.24Fiscal year 2024Operating income−25.2Net income−27.3EPS, diluted−3.26Fiscal year 2025Operating income−22.5Net income−22.2EPS, diluted−1.06
FY2023FY2024FY2025
Operating income −25.0 −25.2 −22.5
Net income −24.7 −27.3 −22.2
Growth
EPS, diluted −17.24 −3.26 −1.06

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2023Operating cash flow−21.6Fiscal year 2024Operating cash flow−21.8Fiscal year 2025Operating cash flow−19.2
FY2023FY2024FY2025
Operating cash flow −21.6 −21.8 −19.2

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash3.0Shareholders’ equity−99.6Fiscal year 2024Cash8.6Shareholders’ equity0.1Fiscal year 2025Cash13.2Shareholders’ equity7.9
FY2023FY2024FY2025
Cash 3.0 8.6 13.2
Shareholders’ equity −99.6 0.1 7.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
n/a −26,189.1% −280.5%
−826.0% −292.8% −158.4%
Balance and payout
281.9% 98.9% 43.5%